Cargando…
Identification of GSK3β inhibitor kenpaullone as a temozolomide enhancer against glioblastoma
Cancer stem cells are associated with chemoresistance and rapid recurrence of malignant tumors, including glioblastoma (GBM). Although temozolomide (TMZ) is the most effective drug treatment for GBM, GBM cells acquire resistance and become refractory to TMZ during treatment. Therefore, glioma stem c...
Autores principales: | Kitabayashi, Tomohiro, Dong, Yu, Furuta, Takuya, Sabit, Hemragul, Jiapaer, Shabierjiang, Zhang, Jiakang, Zhang, Guangtao, Hayashi, Yasuhiko, Kobayashi, Masahiko, Domoto, Takahiro, Minamoto, Toshinari, Hirao, Atsushi, Nakada, Mitsutoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624278/ https://www.ncbi.nlm.nih.gov/pubmed/31296906 http://dx.doi.org/10.1038/s41598-019-46454-8 |
Ejemplares similares
-
Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma
por: JIAPAER, Shabierjiang, et al.
Publicado: (2018) -
Identification of antipsychotic drug fluspirilene as a potential anti-glioma stem cell drug
por: Dong, Yu, et al.
Publicado: (2017) -
CBMS-12 PENTAMIDINE; TRANSLATIONAL RESEARCH FOR A NEW CHEMOTHERAPY TARGETING ON GLIOMA CELLS AND GLIOMA STEM CELLS USING DRUG REPOSITIONING
por: Tamai, Sho, et al.
Publicado: (2019) -
RBPJ contributes to the malignancy of glioblastoma and induction of proneural‐mesenchymal transition via IL‐6‐STAT3 pathway
por: Zhang, Guangtao, et al.
Publicado: (2020) -
Gelsolin inhibits malignant phenotype of glioblastoma and is regulated by miR‐654‐5p and miR‐450b‐5p
por: Zhang, Jiakang, et al.
Publicado: (2020)